Scott Yu, Rachel Li and Clair Xie of Zhong Lun Law Firm detail a significant and far-reaching update to China's key law governing both domestic- and foreign-invested companies
Successful U.S. IPO of Chinese EV brand suggests rising investor confidence, but regulatory risks still loom; Burberry wins trademark infringement and unfair competition lawsuit; and China proposes guidelines to it's lithium battery sector amid overcapacity concerns.
Tests for the Greater Bay Area cross-border data verification platform start in the financial industry; Beijing Internet Court decides case to protect natural voices modified by AI; and Chinese mining companies eye opportunities as BHP Group offers to acquire rival
The release of goods and determination of customs duty amounts may be carried out separately. Procedures are facilitated for marketing of domestically produced foreign pharmaceuticals. Government procurement may invite a supplier to cooperate in research and development.
